Debargha Basuli, MD PhD

Nephrology Asst Professor @ECUHealth_IM I Transplant Nephrology @OHSUNephrology I

[Sayed S Rahman @SayedSRahman1]

Comparison of Kidney Assessment Tools :
Traditional and Emerging.

#KDIGO AKI Guidelines 2026
#KIReport

[Katie Wiskar @katiewiskar]

Confession: I LOVE hyponatremia 🤓

(I know, I know. What can I say, I'm a true internist!)

HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary!

Here are my top 10 hyponatremia tips and tricks - a 🧵

[ASN Publications @asnpublications]

Fluid overload occurs frequently in critically ill patients with AKI and is one of the indications for continuous kidney replacement therapy (CKRT). In this article, the authors state that available and emerging tools help predict and monitor volume status more actively and dynamically to best design UF strategies that avoid hypotension but alleviate congestion. https://t.co/pyqCAMGAG2
@GonzaRGuerrero

[Debargha Basuli, MD PhD @DebarghaBasuli]

@arkanalabs I meant anti-GBM Disease

[Debargha Basuli, MD PhD @DebarghaBasuli]

@arkanalabs Can be GBM too

[KIDNEYcon @KIDNEYcon]

KIDNEYcon Registration is Open!
April 6-8, 2024
Little Rock, AR
https://t.co/WR0UUcbmUN

Little Rock will experience the 2024 Total Solar Eclipse
Discount room rates at the DoubleTree Hotel!

@NephroRock @nephrosharma @nephrosingh @VelezNephHepato @kidney_boy

[Alan Yu🇭🇰 @AlanYuNeph]

Re-reading excellent thread by
@NephroMD. In Winzeler paper, UOsm>=500 is highly specific for non-responsiveness but v. insensitive

🤔How about:
UOsm>500: don't bother with FR
UOsm<300: FR should be first-line approach
300-500: Consider trial of FR
❓

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

DARE-ESKD 1: Pharmacokinetic Properties of SGLT2 inhibitor (SGLT2i) Dapagliflozin in Patients on Hemodialysis and Peritoneal Dialysis ca. 2023 from @CJASN #Nephpearls

- Well tolerated
- Slightly dialyzable
- Non-accumulating pharmacokinetic properties

https://t.co/cTRliEUxPG

[Joel M. Topf, MD FACP @kidney_boy]

Looks like you can #Flozinate your dialysis patients!

"In individuals with kidney failure on dialysis, dapagliflozin was well-tolerated, slightly dialyzable, and had non-accumulating pharmacokinetic properties"

https://t.co/EUs4jsFEop

[KIReports @KIReports]

✅IT OUT 👇
📢📢📢Tweetorial Alert (1/19)!
What is the most common complication of routine outpatient hemodialysis (HD) treatments?

[GlomCon @GlomCon]

Genomics in Glomerular Disease
A GlomCon Pubs summary on genetic diagnoses of glomerular diseases by Dr. Benjamin Tan @NephBen

Read more 👉🏻 https://t.co/HCnimnzIdv

#GlomCon

[Kitching Laboratory @KitchingLab]

Our article in @NatRevImmunol proposes that nephritis can be classified primarily according to cause, then by the lesion. This would improve management, education, understanding and research.
Thanks to @hjanders_hans @PRomagnani and Prof Nelson Leung for a great collaboration.

[Debargha Basuli, MD PhD @DebarghaBasuli]

@kidney_boy Found it. Thanks a lot!

[Renal Fellow Network @RenalFellowNtwk]

A nice refresher of high yield kidney disorders!
#TBThursday
-md
https://t.co/cGk9vfze4Q

[Debargha Basuli, MD PhD @DebarghaBasuli]

https://t.co/R1INzsQmU0

[Eduardo R Argaiz @ArgaizR]

Ambulatory Hemodialysis Unit Rounds:

Called to see a patient with hypotension: BP 76/40,🧠 OK, CRT 5 seconds

1st step ➡️🛑Ultrafiltration + 300 ml bolus. BP 90/60

Pt is a middle aged ♂️ w ESRD and T2DM

1/9 🧵

[Raviele Antonio @drraviele]

📌 A very comprehensive stepwise ECG algorithm
👉 to predict site of origin of idiopathic VAs
#ECG #CardioTwitter #EPeeps @adribaran @ECGTalk @DrFerminGarcia @DrJasonAndrade @DhirajGuptaBHRS @SeguraCardio @jvillacastin @smithECGBlog @AskDrShashank @ecgrhythms @iamritu @Hragy

[Eduardo R Argaiz @ArgaizR]

#AKIConsultSeries:👨w T2DM➡️🏥 for fever, dysuria and CVA tenderness. On arrival: ⬇️BP, ⬆️Glucose, ⬆️AGMA. Dx UTI + DKA. Tx: Abx + Insulin Pump + 4 L Crystalloid + NE

After resus, pt still oliguric, Cr 3.2. NE 0.7 ug/kg/min,🧠confused, BP 85/62, HR 123, 2L O2. CRT 4 sec

1/12

[@CKD_ce @ckd_ce]

1) Welcome to this new #accredited #tweetorial on best practices for providing #interprofessional, multidisciplinary, and multimodal pharmacologic therapy for patients with #CKD-associated anemia #aCKD. #MedTwitter #FOAMed #nephtwitter @MedTweetorials